Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × elemene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Advanced Primary Liver Cancer 2 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Cisplatin 45 Carboplatin 40 pembrolizumab 38 Paclitaxel 34 Gemcitabine 27 Radiotherapy 19 Pemetrexed 18 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 16 Cetuximab 16 Specimen Handling 15 Nivolumab 14 Fluorouracil 13 Cyclophosphamide 13 durvalumab 12 Sorafenib 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 Bevacizumab 9 osimertinib 8 Radiation 8 Oxaliplatin 8 1,2-diaminocyclohexaneplatinum II citrate 8 Irinotecan 7 Everolimus 7 Drug Therapy 7 Capecitabine 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡